European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Effects of oral appliances and CPAP on the left ventricle and natriuretic peptides

Hoekema, A., Voors, A. A., Wijkstra, P. J., Stegenga, B., van der Hoeven, J. H., Tol, C. G., & de Bont, L. G. M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.06.016 · Cited by 81

A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography

Boi, A., Jamthikar, A. D., Saba, L., Gupta, D., Sharma, A., Loi, B., Laird, J. R., Khanna, N. N., & Suri, J. S. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0736-8 · Cited by 83

Coronary calcification score: the coronary-risk impact factor

Thompson, G., & Partridge, J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15544-x · Cited by 82

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial

Stender, S., Schuster, H., Barter, P. J., Watkins, C. J., Kallend, D. G., & on behalf of the MERCURY I Study Group (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00450.x · Cited by 81

Guidelines on the management of stable angina pectoris

Skalidis, E. I., & Vardas, P. E. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl257 · Cited by 80

Functional foods for dyslipidaemia and cardiovascular risk prevention

Sirtori, C. R., Galli, C., Anderson, J. W., Sirtori, E., & Arnoldi, A. (2009) · Nutrition Research Reviews · doi:10.1017/s0954422409990187 · Cited by 79

Cardiac history, prior depression and personality predict course of depressive symptoms after myocardial infarction

Martens, E. J., Smith, O. R. F., Winter, J., Denollet, J., & Pedersen, S. S. (2007) · Psychological Medicine · doi:10.1017/s0033291707001377 · Cited by 83

Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL)

Mazza, A., Zamboni, S., Rizzato, E., Pessina, A. C., Tikhonoff, V., Schiavon, L., & Casiglia, E. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0249-3 · Cited by 79

Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007

(ESH), G. D. T. P. E. T. D. L. H. A. D. L. S. E. D. H., & de Cardiología, D. L. S. E. (2007) · Revista Española de Cardiología · doi:10.1157/13109650 · Cited by 79

Multiple stressors and coronary disease in women

Orth‐Gomér, K., & Leineweber, C. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2004.11.005 · Cited by 81

Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practiceA descriptive epidemiological study

Getz, L., Kirkengen, A. L., Hetlevik, I., Romundstad, S., & Sigurdsson, J. A. (2004) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430410006693 · Cited by 79

Recent applications of paper‐based point‐of‐care devices for biomarker detection

Suntornsuk, W., & Suntornsuk, L. (2019) · Electrophoresis · doi:10.1002/elps.201900258 · Cited by 81

Depressive symptoms in peripheral arterial disease: A follow-up study on prevalence, stability, and risk factors

Smolderen, K. G. E., Aquarius, A. E., Vries, J. D., Smith, O. R. F., Hamming, J. F., & Denollet, J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.12.238 · Cited by 78

First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)

Alkerwi, A., Sauvageot, N., Donneau, A., Lair, M., Couffignal, S., Beissel, J., Delagardelle, C., Wagener, Y., Albert, A., & Guillaume, M. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-468 · Cited by 79

Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries

Campbell, S., Ludt, S., van Lieshout, J., Boffin, N., Wensing, M., Petek, D., Grol, R. P. T. M., & Roland, M. O. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328302f44d · Cited by 78

Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database

Awa, W. L., Fach, E.-M., Krakow, D., Welp, R., Kunder, J., Voll, A., Zeyfang, A., Wagner, C., Schütt, M., Boehm, B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0143 · Cited by 77

Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative

den Ruijter, H. M., Peters, S. A. E., Groenewegen, K. A., Anderson, T. J., Britton, A. R., Dekker, J. M., Engström, G., Eijkemans, M. J. C., Evans, G. W., Graaf, J. D., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2898-9 · Cited by 75

Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease – evidence from systematic reviews of randomized controlled trials (second update, January 2006)

Mead, A., Atkinson, G., Albin, D., Alphey, D., Baic, S., Boyd, O., Cadigan, L., Clutton, L., Craig, L., Flanagan, C., et al. (2006) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2006.00726.x · Cited by 79

Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines

Mortensen, M. B., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.1876 · Cited by 75

Cardiovascular risk in patients with bipolar disorder

García‐Portilla, M. P., Sáiz, P. A., Bobes-Bascarán, T., Martíneza, S., Benabarre, A., Sierra, P., Torres, P., Montes, J. M. G., Bousoño, M., & Bobes, J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.008 · Cited by 80

A qualitative study of lifestyle counselling in general practice in Ireland

Lambe, B., & Collins, C. (2009) · Family Practice · doi:10.1093/fampra/cmp086 · Cited by 76

Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings

Ceriello, A. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.038 · Cited by 76

Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial

Vernooij, J. W. P., Kaasjager, K. A. H., van der Graaf, Y., Wierdsma, J. M., Grandjean, H. M. H., Hovens, M. M. C., de Wit, G. A., Visseren, F. L. J., & on behalf of the SMART study group (2012) · BMJ · doi:10.1136/bmj.e3750 · Cited by 74

Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial

Loon, M. S. K.-V., van der Weijden, T., van Steenkiste, B., Ronda, G., Winkens, B., Severens, J. L., Wensing, M., Elwyn, G. J., & Grol, R. P. T. M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081591 · Cited by 75

The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery

Naughton, C., & Feneck, R. O. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01304.x · Cited by 75

Cardiac and vascular complications in rheumatoid arthritis

Rawla, P. (2019) · Reumatologia/Rheumatology · doi:10.5114/reum.2019.83236 · Cited by 78

Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease

Apostolakis, S. Z., Baritaki, S., Kochiadakis, G. E., Igoumenidis, N. E., Panutsopulos, D., & Spandidos, D. A. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.12.016 · Cited by 75

The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study

Mortensen, M. B., Afzal, S., Nordestgaard, B. G., & Falk, E. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv251 · Cited by 64

Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey

Kotseva, K., Stagmo, M., Bacquer, D. D., Backer, G. D., & Wood, D. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.004 · Cited by 72

Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the ‘Florence’ diet is not Mediterranean

Sofi, F., Vecchio, S. L., Giuliani, G., Marcucci, R., Gori, A. M., Fedi, S., Casini, A., Surrenti, C., Abbate, R., & Gensini, G. F. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602112 · Cited by 73

Aged Garlic Extract Retards Progression of Coronary Artery Calcification

Budoff, M. J. (2006) · Journal of Nutrition · doi:10.1093/jn/136.3.741s · Cited by 74

Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides.

Musa-Veloso, K., Binns, M. A., Kocenas, A. C., Poon, T., Elliot, J. A., Rice, H., Oppedal-Olsen, H., Lloyd, H., & Lemke, S. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00272.x · Cited by 73

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study

Berne, C., Siewert-Delle, A., & the URANUS study investigators (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-7 · Cited by 73

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

Sasso, F. C., Simeon, V., Galiero, R., Caturano, A., Nicola, L. D., Chiodini, P., Rinaldi, L., Salvatore, T., Lettieri, M., Nevola, R., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01674-7 · Cited by 71

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

Authors Task Force Members, Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., et al. (2007) · European Heart Journal Supplements · doi:10.1093/eurheartj/ehl261 · Cited by 76

A physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with type 2 diabetes mellitus

Lazarević, G., Antić, S., Cvetković, T., Vlahović, P., Tasic, I. S., & Stefanović, V. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70312-9 · Cited by 73

Different forms of physical activity and cardiovascular risk factors among 24-64-year-old men and women in Finland

Barengo, N. C., Kastarinen, M. J., Lakka, T. A., Nissinen, A. M., & Tuomilehto, J. O. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200602000-00008 · Cited by 75

Best practice in primary care pathology: review 3

Smellie, W. S. A., Forth, J., Bareford, D., Twomey, P. J., Galloway, M. J., Logan, E. C. M., Smart, S., Reynolds, T., & Waine, C. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.200x.033944 · Cited by 73

Epigenetic Link Between Statin Therapy and Type 2 Diabetes

Ochoa‐Rosales, C., Portilla-Fernández, E., Nano, J., Wilson, R., Lehne, B. C., Mishra, P. P., Gao, X., Ghanbari, M., Rueda-Ochoa, O. L., Juvinao-Quintero, D. L., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1828 · Cited by 70

Design of a Fuzzy-based Decision Support System for Coronary Heart Disease Diagnosis

Lahsasna, A., Ainon, R. N., Zainuddin, R., & Bulgiba, A. M. (2012) · Journal of Medical Systems · doi:10.1007/s10916-012-9821-7 · Cited by 71

Adherence to preventive statin therapy according to socioeconomic position

Wallach‐Kildemoes, H., Andersen, M. T., Diderichsen, F., & Lange, T. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1488-6 · Cited by 71

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials

McAlister, F. A., & for the Renin Angiotension System Modulator Meta-Analysis Investigators (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr400 · Cited by 71

Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease

Emanuelsson, F., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Benn, M. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.037 · Cited by 69

Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation

Erbel, R., Möhlenkamp, S., Lehmann, N., Schmermund, A., Moebus, S., Stang, A., Grönemeyer, D. H. W., Seibel, R. M. M., Mann, K., Volbracht, L., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.02.031 · Cited by 71

Management of Dyslipidemia in the Metabolic Syndrome

Ascaso, J. F., Santos, P. G., Mijares, A. H., Mangas, A., Masana, L., Millán, J., Pallardo, L. F., Pedro‐Botet, J., Jiménez, F. P., Pintó, X., et al. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707010-00004 · Cited by 79

Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis

Aboyans, V., McClelland, R. L., Allison, M., McDermott, M. M., Blumenthal, R. S., Macura, K. J., & Criqui, M. H. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.011 · Cited by 70

Gender differences in the lipid profile of dyslipidemic subjects

Kolovou, G. D., Anagnostopoulou, K. K., Damaskos, D. S., Bilianou, H. I., Mihas, C. C., Milionis, H. J., Kostakou, P. M., & Cokkinos, D. V. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.06.011 · Cited by 70

Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up study

Hermes, W., Tamsma, J. T., Grootendorst, D. C., Franx, A., van der Post, J., van Pampus, M. G., Bloemenkamp, K. W. M., PORATH, M. M., Mol, B. W., & de Groot, C. J. M. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-126 · Cited by 70

Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries

Hermans, M. P., Cabezas, M. C., Strandberg, T. E., Ferrières, J., Feely, J., Elisaf, M., Michel, G., & Sansoy, V. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903500565 · Cited by 70

Global Cardiovascular Risk in Patients with HIV Infection: Concordance and Differences in Estimates According to Three Risk Equations (Framingham, SCORE, and PROCAM)

Knobel, H., Jericó, C. R., Montero, M., Sorlí, L., Velat, M., Guelar, A., Saballs, P., & Pedro‐Botet, J. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.0165 · Cited by 71

Type D personality and depressive symptoms are independent predictors of impaired health status following acute myocardial infarction

Mols, F., Martens, E. J., & Denollet, J. (2009) · Heart · doi:10.1136/hrt.2009.170357 · Cited by 71

A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998

Neuhauser, H. K., Ellert, U., & Kurth, B. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000183909.52118.9f · Cited by 69

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?

Feigin, V. L., Brainin, M., Norrving, B. G., Gorelick, P. B., Dichgans, M., Wang, W., Pandian, J. D., Martins, S. C. O., Owolabi, M. O., Wood, D. A., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014494 · Cited by 73

Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians

van Steenkiste, B., van der Weijden, T., Stoffers, J., Kester, A. D. M., Timmermans, D. R. M., & Grol, R. P. T. M. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000239475.71805.1e · Cited by 69

Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome

Sode-Carlsen, R., Farholt, S., Rabben, K. F., Bollerslev, J., Schreiner, T., Jurik, A. G., Christiansen, J. S., & Höybye, C. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.12.004 · Cited by 68

Patient Factors Influencing the Prescribing of Lipid Lowering Drugs for Primary Prevention of Cardiovascular Disease in UK General Practice: A National Retrospective Cohort Study

Wu, J., Zhu, S., Yao, G., Mohammed, M. A., & Marshall, T. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067611 · Cited by 69

Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study

Buyken, A. E., von Eckardstein, A., Schulte, H., Cullen, P., & Assmann, G. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3280142037 · Cited by 72

Forecasting drug utilization and expenditure in a metropolitan health region

Wettermark, B., Persson, M. E., Wilking, N. E., Kalin, M., Korkmaz, S., Hjemdahl, P., Godman, B., Petzold, M., & Gustafsson, L. L. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-128 · Cited by 70

Controversies in stable coronary artery disease

Opie, L. H., Commerford, P., & Gersh, B. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67927-0 · Cited by 69

Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment

Hecht, H. S., Budoff, M. J., Berman, D. S., Ehrlich, J., & Rumberger, J. A. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.07.018 · Cited by 67

Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

Steinhagen‐Thiessen, E., Bramlage, P., Lösch, C., Hauner, H., Schunkert, H., Vogt, A., Wasem, J., Jöckel, K., & Moebus, S. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-31 · Cited by 68

The risk factors and prevention of cardiovascular disease: the importance of electrocardiogram in the diagnosis and treatment of acute coronary syndrome

Rosiek, A. B., & Leksowski, K. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s107849 · Cited by 75

The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.

Blackburn, P., Lemieux, I., Alméras, N., Bergeron, J., Côté, M., Tremblay, A., Lamarche, B., & Després, J.-P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.012 · Cited by 67

Association of Perceived Stress Levels With Long-term Mortality in Patients With Peripheral Artery Disease

Malik, A. O., Peri-Okonny, P., GOSCH, K. L., Thomas, M. B., Mena, C. I., Hiatt, W. R., Jones, P. G., Provance, J., Labrosciano, C., Jelani, Q., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8741 · Cited by 69

Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease

Kryczka, K., Kruk, M. B. P., Demkow, M., & Lubiszewska, B. (2021) · Biomolecules · doi:10.3390/biom11071036 · Cited by 69

N-Terminal Pro Brain Natriuretic Peptide in Arterial Hypertension—A Marker for Left Ventricular Dimensions and Prognosis

Hildebrandt, P. R., Boesen, M., Olsen, M. H., Wachtell, K., & Groenning, B. A. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.01.001 · Cited by 65

Current lipid management and low cholesterol goal attainment in common daily practice in Spain

REALITY Study Group, Ruiz, F., Ibañez, A. M., Jiménez, F. P., Pintó, X., Nocea, G., Ahumada, C. D., Alemao, E., & Yin, D. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422003-00002 · Cited by 67

Analysis of Metabolic Syndrome in Adult Dermatomyositis With a Focus on Cardiovascular Disease

de Moraes, M. T., de Souza, F. H. C., Barros, T. B. M., & Shinjo, S. K. (2012) · Arthritis Care & Research · doi:10.1002/acr.21879 · Cited by 66

Rosuvastatina y metformina reducen la inflamación y el estrés oxidativo en pacientes con hipertensión y dislipemia

Gómez‐García, A., Torres, G. M., Ortega-Pierres, L. E., Rodríguez-Ayala, E., & Álvarez-Aguilar, C. (2007) · Revista Española de Cardiología · doi:10.1157/13113929 · Cited by 66

Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists

Collins, P., Rosano, G., Casey, C., Daly, C., Gambacciani, M., Hadji, P., Kaaja, R., Mikkola, T., Palacios, S., Preston, R., et al. (2007) · Climacteric · doi:10.1080/13697130701755213 · Cited by 67

Statins and C‐Reactive Protein Levels

Asher, J., & Houston, M. (2007) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06639.x · Cited by 65

Differences in Atherosclerotic Plaque Burden and Morphology Between Type 1 and 2 Diabetes as Assessed by Multislice Computed Tomography

Djaberi, R., Schuijf, J. D., Boersma, E. H., Kroft, L. J. M., Pereira, A. M., Romijn, J. A., Scholte, A. J. H. A., Jukema, J. W., & Bax, J. J. (2009) · Diabetes Care · doi:10.2337/dc09-0320 · Cited by 65

A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients’ modifiable risk factor profile

Benner, J. S., Erhardt, L., Flammer, M., Moller, R. A., Rajicic, N., Changela, K., Yunis, C., Cherry, S. B., Gaciong, Z. A., Johnson, E. S., et al. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01872.x · Cited by 66

Evaluation of cardiovascular risk predicted by different SCORE equations: The Netherlands as an example

van Dis, I., Kromhout, D., Geleijnse, J. M., Boer, J. M. A., & Verschuren, W. M. M. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328337cca2 · Cited by 67

Women and coronary disease

Andreotti, F., & Marchese, N. (2007) · Heart · doi:10.1136/hrt.2005.072769 · Cited by 64

Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future

Revkin, J. H., Shear, C. L., Pouleur, H. G., Ryder, S. W., & Orloff, D. G. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.1 · Cited by 66

Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines on Cardiovascular Disease Prevention: the SMART study.

Goessens, B., Visseren, F., Algra, A., Banga, J., & van der Graaf, Y. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.11.050 · Cited by 71

Effects of Aerobic Exercise on Microalbuminuria and Enzymuria in Type 2 Diabetic Patients

Lazarević, G., Antić, S., Vlahović, P., et al. (2007) · Renal Failure · doi:10.1080/08860220601098870 · Cited by 64

Prevalence of Cardiovascular Risk Factors in Older People With Intellectual Disability

de Winter, C. F., Magilsen, K. W., van Alfen, J. C., Penning, C., & Evenhuis, H. M. (2009) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-114.6.427 · Cited by 65

Applying the Evidence

Saposnik, G., Goodman, S. G., Leiter, L. A., Yan, R. T., FITCHETT, D. H., Bayer, N., Casanova, A., Langer, A., Yan, A. T.-K., & Guidelines-Oriented Approach to Lipid-Lowering (GOALL) Registries Investigators (2009) · Stroke · doi:10.1161/strokeaha.108.533018 · Cited by 64

Food and Western Disease Health and Nutrition from an Evolutionary Perspective

Lindeberg, S. (2009) · Cited by 64

Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects

Accinni, R., Rosina, M., Bamonti, F., Noce, C. D., Tonini, A., Bernacchi, F., Campolo, J., Caruso, R., Novembrino, C., Ghersi, L., et al. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.05.006 · Cited by 63

Arterial calcification: Friend or foe?

Nicoll, R., & Henein, M. Y. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.110 · Cited by 63

Red Blood Cell Fatty Acid Patterns and Acute Coronary Syndrome

Shearer, G. C., Pottala, J. V., Spertus, J. A., & Harris, W. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005444 · Cited by 64

The role of community programmes and mass events in promoting physical activity to patients: Table 1

Bauman, A. E., Murphy, N. M., & Lane, A. (2008) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.054189 · Cited by 63

Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial

Jakobsen, A. S., Speyer, H., Nørgaard, H. C. B., Karlsen, M., Birk, M., Hjorthøj, C. R., Mors, O. N., Krogh, J., Gluud, C. N., Pisinger, C. H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185881 · Cited by 61

Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study

Honda, T., Chen, S., Hata, J., Yoshida, D., Hirakawa, Y., Furuta, Y., Shibata, M., Sakata, S., Kitazono, T., & Ninomiya, T. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.61960 · Cited by 62

Associations between acute lipid stress responses and fasting lipid levels 3 years later.

Steptoe, A., & Brydon, L. (2005) · Health Psychology · doi:10.1037/0278-6133.24.6.601 · Cited by 63

LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes

Eliasson, B., Guðbjörnsdóttir, S., Zethelius, B., Eeg‐Olofsson, K., & Cederholm, J. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313494292 · Cited by 62

Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001

Hartz, I., Njølstad, I., & Eggen, A. E. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi556 · Cited by 61

Manageability, vulnerability and interaction: A qualitative analysis of acute myocardial infarction patients’ conceptions of the event

Johansson, I., Swahn, E., & Strömberg, A. (2006) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2006.08.003 · Cited by 61

A Randomized, Placebo‐Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial

Preston, R. A., Harvey, P., Herfert, O., Dykstra, G., Jukema, J. W., Sun, F., & Gillen, D. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007307879 · Cited by 60

Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes

Srivastava, P., Calafiore, P. A., MacIsaac, R. J., Patel, S. K., Thomas, M. C., Jerums, G., & Burrell, L. M. (2008) · Clinical Science · doi:10.1042/cs20070261 · Cited by 61

Glycaemic instability is an underestimated problem in Type II diabetes

Praet, S., MANDERS, R. J. F., Meex, R. C. R., Lieverse, A. G., Stehouwer, C. D. A., Kuipers, H., KEIZER, H. A., & van Loon, L. J. C. (2006) · Clinical Science · doi:10.1042/cs20060041 · Cited by 61

Cardiovascular risk and adrenergic overdrive in the metabolic syndrome

Grassi, G. M., Quarti‐Trevano, F., Seravalle, G., & Dell’Oro, R. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.004 · Cited by 61

Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases

Younis, N. K., Ghoubaira, J. A., Bassil, E. P., Tantawi, H. N., & Eid, A. H. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102433 · Cited by 64

Community response to environmental noise and the impact on cardiovascular risk score

Argalášová, Ľ., Jurkovičová, J., Štefániková, Z., Ševčíková, Ľ., & Ághová, Ľ. (2010) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2009.12.033 · Cited by 60

Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study

Leiter, L. A., Rosenson, R. S., Stein, E. A., Reckless, J. P. D., Schulte, K.-L., Schleman, M. M., Miller, P., Palmer, M. K., & Sosef, F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.001 · Cited by 61

The Clinical Manifestation of Myocardial Infarction in Elderly Patients

Goch, A., Misiewicz, P., Rysz, J., et al. (2009) · Clinical Cardiology · doi:10.1002/clc.20354 · Cited by 60

Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up

Tuikkala, P., Hartikainen, S. A., Korhonen, M. J., Lavikainen, P., Kettunen, R., Sulkava, R. O., & Enlund, H. (2010) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2010.487371 · Cited by 60

Committee and Task Force Reports: Youth and Families Task Force Report

James, S., Jordan, K., Lasser, J. S., et al. (1997) · PsycEXTRA Dataset · doi:10.1037/e413432005-005

Ethnic Minority Elderly: A Task Force Report of the American Psychiatric Association

Busse, E. W. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199524310-00013 · Cited by 1

Committee and Task Force Reports: Task Force on Aging

Carlson, H. M., & David, S. (2004) · PsycEXTRA Dataset · doi:10.1037/e373992004-024

Committee and Task Force News: Task Force on Students-at-Risk

Kaslow, F. W., & Olson, D. L. (1991) · PsycEXTRA Dataset · doi:10.1037/e410102005-024 · Cited by 1

Update From the American Psychiatry Association's Task Force on Electroconvulsive Therapy

McDonald, W. M., Prudic, J., McCall, W. V., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.078 · Cited by 3